重大事件
即時報告
8-K
2026-06-09
Cocrystal Pharma 提交8-K報告 揭露董事離職與高層人事變動
AI 繁中摘要
Cocrystal Pharma, Inc. 提交了一份 8-K 當前報告 📄，報告日期為 2026 年 6 月 3 日。該文件主要觸發 Item 5.02，涉及董事或特定高管的離職、選舉、任命以及相關補償安排。公司同時附上一份重大協議（EX-10.1），具體條款尚未公開。Cocrystal Pharma 為一家專注抗病毒藥物開發的生物製藥公司，總部位於華盛頓州 Bothell。是次申報未披露任何財務數字或管理層業績展望，但高層人事變動可能影響公司短期決策與研發節奏 🧪。投資者宜密切關注後續細節，以評估對股權結構與營運穩定性的潛在影響 💡。
展開英文正文
EDGAR Filing Documents for 0001493152-26-027837 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001493152-26-027837 Filing Date 2026-06-09 Accepted 2026-06-09 07:00:23 Documents 12 Period of Report 2026-06-03 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K form8-k.htm iXBRL 8-K 42933 2 EX-10.1 ex10-1.htm EX-10.1 25671 Complete submission text file 0001493152-26-027837.txt 239634 Data Files Seq Description Document Type Size 3 XBRL SCHEMA FILE cocp-20260603.xsd EX-101.SCH 3035 5 XBRL LABEL FILE cocp-20260603_lab.xml EX-101.LAB 34239 6 XBRL PRESENTATION FILE cocp-20260603_pre.xml EX-101.PRE 22372 16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3074 Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831 Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings) EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 261074565 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)